Lumipulse® G SARS-CoV-2 N-IgG Controls
For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System. The assay using this control is performed to quantitatively measure IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma and is intended to be used in the assessment of the immune response to the SARS-CoV-2 N protein.
CE marked
Lumipulse® G SARS-CoV-2 N-IgG Controls
Product number 232354
2 x 2 Concentrations
Click here to navigate
- Contact sales for information
- Conditions of sale
- Documentation
- Insights
- Related products
- Product inquiry
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
Jan 6, 2022Oct 19, 2020 -
Related products
-
Product inquiry